2018-08-01   Jean-Loup Huret


Review on der(8;17)(q10;q10), with data on clinics.

Clinics and Pathology


Lymphoid and myeloid malignancies. All lymphoid cases were B Lineage. There were 5 cases of chronic lymphocytic leukemia (CLL) (Döhner et al., 1995; Geisler et al., 1997; Adeyinka et al., 2007; Tang et al., 2013), 1 case of B-prolymphocytic leukemia (Schlette et al., 2001), and 1 case of Waldenstrom macroglobulinemia (Wong 2003). There were also 2 myeloid cases; one acute myeloblastic leukemia without maturation (M1-AML) and one acute myeloblastic leukemia with maturation (M2-AML) (respectively Kim et al., 2001 and Mrózek et al., 2002).


der(8;17)(q10;q10) is also a recurrent abnormality in adenocarcinoma of the large intestine.


The 5 chronic lymphocytic leukemia cases were male patients, aged 50, 84, 92, ?, ?. The B-prolymphocytic leukemia case was a male patient, the Waldenstrom case a female patient aged 80 years, the AMLs cases a male and a female patient aged 68 years.


In only one chronic lymphocytic leukemia case was the survival noted: 52 months of treatment-free survival (Tang et al., 2013).



A der(8;17)(q10;q10) is an unbalanced translocation, with 8p and 17 deletions.

Cytogenetics morphological

The der(8;17)(q10;q10) was the sole abnormality in 2 CLL cases, and the sole abnormality within a sideline in the Waldenstrom case (an i(17q) was found in another subclone). A t(14;18)(q32;q21) was present in 2 CLL cases; +12, del(13q), and a complex karyotype were found in 1 CLL case each. The B-prolymphocytic leukemia also had del(7q), del(11q). The 2 AMLs had a del(5q), and a complex karyotype, the M1-AML also presented with del(3p), and the M2-AML with t(10;16)(q22;p13) KAT6B/CREBBP, +19.

Result of the Chromosomal Anomaly


Genes implicated in oncogenesis in these cases are unknown. Nevertheless it should be noted that the chromosome abnormality results in TP53 deletion.


Pubmed IDLast YearTitleAuthors
173213292007Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies.Adeyinka A et al
78886751995p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.Döhner H et al
94449331997In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.Geisler CH et al
113437752001The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes.Kim MH et al
119795482002Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.Mrózek K et al
112939062001Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.Schlette E et al
230845812013Chronic lymphocytic leukemia with t(14;18)(q32;q21).Tang G et al
125819042003Waldenström macroglobulinemia with a novel der(8;17)(q10;q10).Wong KF et al


Jean-Loup Huret


Atlas Genet Cytogenet Oncol Haematol. 2018-08-01

Online version:;17)(q10;q10)